BioSpace News Archive

Vyera Pharmaceuticals, LLC acknowledges the decision announced by the U.S. Federal Trade Commission and the New York State Office of the Attorney General to file a civil action against Vyera, its parent company, and certain former members of its management relating to Daraprim®, which is a prescription drug used in combination with sulfonamide for the treatment of toxoplasmosis.

Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers

Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it has executed a definitive agreement with the University of Geneva for an exclusive global license to a novel drug discovery platform for the generation of G protein coupled receptor (GPCR) chemokine analogs.

CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announces it has completed all payment obligations for the June 2019 acquisition of New Jersey Alternative Medicine (“NJAM”)

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced dosing of the first patient in a Phase 1b clinical trial being conducted under a collaboration with Astellas Pharma Inc., to evaluate the combination of ORIC-101,

Swift Biosciences, Inc (“Swift”) and Opentrons Labworks, Inc. (“Opentrons”) today at the SLAS2020 conference announce their partnership to leverage Swift’s efficient NGS library preparation kits on Opentrons’ open-source automation platform.

Eight Cochlear recipients recognized for their achievements in academia, leadership and humanity with $64,000 in funding for further academic endeavors

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions, nucleic acid-based biotherapeutic development and liquid biopsies, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it United States patent no. 10,519,605 entitled “Methods of Marking Cellulosic Products.”

Precision for Medicine, the first comprehensive, fully-integrated biomarker-driven clinical research services organization, today announced that veteran healthcare leader Mairead Kehoe has been named its new Executive Vice President, responsible for overseeing its global clinical solutions delivery.

The Chief Public Health Officer, Dr. Theresa Tam, and the Deputy Chief Public Health Officer, Dr. Howard Njoo, will hold a media availability to provide an update on a novel coronavirus..